colforsin has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brehm, MA; Gallagher, KM; Green, MR; Greiner, DL; Kelliher, MA; Murphy, LC; O'Connor, KW; Roderick, JE; Tang, K; Yu, J; Zhang, B; Zhu, LJ | 1 |
1 other study(ies) available for colforsin and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Child; Chromogranins; Colforsin; Cyclic AMP; Dexamethasone; Dinoprostone; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Leukemic; GTP-Binding Protein alpha Subunits, Gs; Humans; Male; Mice; Models, Animal; Molecular Targeted Therapy; Neoplasm Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Radiation Chimera; Receptors, Glucocorticoid; Receptors, Prostaglandin E, EP4 Subtype; RNA Interference; RNA, Small Interfering; Second Messenger Systems; Xenograft Model Antitumor Assays | 2021 |